Facebook
Twitter
LinkedIn
ForwardJinwoo Park, Jin-Woo Park, MD, PhD 73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea, [email protected]
Dr. Park's research over the past years has focused on the autonomic disorders, neurological rare diseases including amyotrophic lateral sclerosis (ALS), and clinical pharmacology in various neurological disorders (early clinical trials and pharmacogenomics).
Dr. Park was trained as a physician-scientist and was appointed as Korean representative of the Young Neurophysiologists Network (YNN) in the International Federation of Clinical Neurophysiology (IFCN).
His work in rare neurological disorders is also focused on multiple sclerosis and neuromyelitis optica spectrum disorders (NMOSD) to find novel biomarkers and new therapeutics related to this.
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:09/29/2022Date updated:09/28/2022
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.